RepliCel Life Sciences Inc. has appointed as CFO Simon Ma, who serves in that position for a number of other public companies.

Ma has been the company's director of finance since June 2016 and would replace Tom Kordyback, who resigned as the company's CFO. Ma is also CFO of various public companies listed on the TSX Venture Exchange or the Canadian Securities Exchange.

Vancouver, British Columbia-based RepliCel Life Sciences is a regenerative-medicine company that develops autologous cell therapies that treat functional cellular deficits.